Wall Street analysts are making their voices heard, issuing new ratings and price targets for several notable companies. This week, several analysts have initiated coverage on companies, providing valuable insights for investors.
Tandem Diabetes Care (TNDM)
: Goldman Sachs analyst David Roman has initiated coverage on Tandem Diabetes Care with a Neutral rating and a price target of $46. This comes as Tandem Diabetes Care shares closed at $40.46 on Thursday, down 1.7%.
Mural Oncology plc (MURA)
: Raymond James analyst Laura Prendergast has initiated coverage on Mural Oncology with a Strong Buy rating and a price target of $18. Mural Oncology shares closed at $3.20 on Thursday, up 2.6%.
ASP Isotopes Inc. (ASPI)
: Canaccord Genuity analyst George Gianarikas has initiated coverage on ASP Isotopes with a Buy rating and a price target of $4.5. ASP Isotopes shares closed at $3.01 on Thursday, up 11.1%.
Curbline Properties Corp. (CURB)
: JP Morgan analyst Michael Mueller has initiated coverage on Curbline Properties with an Overweight rating and a price target of $25. Curbline Properties shares closed at $22.60 on Thursday, up 4.3%.
MINISO Group Holding Limited (MNSO)
: Citigroup analyst Xiaopo Wei has initiated coverage on MINISO Group with a Buy rating and a price target of $26.8. MINISO Group shares closed at $18.96 on Thursday, down 0.2%.These analyst ratings offer valuable insights into the potential future performance of these companies. Investors looking to make informed decisions should consider these ratings, alongside other relevant factors, before making any investment choices.
